Effect of Therapeutic INR on Activated Clotting Times, Heparin Dosage, and Bleeding Risk During Ablation of Atrial Fibrillation

Interaction of vitamin K antagonists with heparin affect monitoring by activated clotting times

(2010) Jorg Muntwyler et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

(2009) Riccardo Cappato et al.   Circulation-Arrhythmia and Electrophysiology

Complications during catheter ablation of atrial fibrillation: Identification and prevention

(2009) Harish Doppalapudi et al.   HEART RHYTHM

Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: A safe and efficacious periprocedural anticoagulation strategy

(2009) Ayman A. Hussein et al.   HEART RHYTHM

Safety and Convenience of Continuous Warfarin Strategy During the Periprocedural Period in Patients Who Underwent Catheter Ablation of Atrial Fibrillation

(2009) JAE-JIN KWAK et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Incidence and Predictors of Periprocedural Cerebrovascular Accident in Patients Undergoing Catheter Ablation of Atrial Fibrillation

(2009) DANIEL SCHERR et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Atrial Fibrillation Ablation in Patients with Therapeutic International Normalized Ratios

(2009) MARTIN SCHMIDT et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY